Acta Pharmaceutica Sinica B
|
2025, 15(7): 3460-3486
• Reviews •
Extracellular vesicles as biomarkers and drug delivery systems for tumor
Full
Xue Wang1,2, Wenjing Chen1,2, Wei Zeng1,2, Kuanhan Feng1,2, Yu Zheng1,2, Ping Wang1,2, Fucai Chen1,2, Wen Zhang1,2, Liuqing Di1,2, Ruoning Wang1,2
Affiliations
1 School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;
2 Jangsu Provincial TCM Engineering Technology Research Center of High Efficient Drug Delivery System, Nanjing 210023, China
doi: 10.1016/j.apsb.2025.04.033
Outline
Extracellular vesicles (EVs) are crucial for facilitating intercellular communication, promoting cell migration, and orchestrating the immune response. Recently, EVs can diagnose and treat tumors. EVs can be measured as biomarkers to provide information about the type of disease and therapeutic efficacy. Furthermore, EVs with lower immunogenicity and better biocompatibility are natural carriers of chemicals and gene drugs. Herein, we review the molecular composition, biogenesis, and separation methods of EVs. We also highlight the important role of EVs from different origins as biomarkers and drug delivery systems in tumor therapy. Finally, we provide deep insights into how EVs play a role in reversing the immunosuppressive microenvironment.
Extracellular vesicles
/
Biomarkers
/
Tumor immunotherapy
/
Drug delivery systems
/
Tumor microenvironment
/
Drug loading methods
/
Separation technologies
/
Molecular composition
Xue Wang, Wenjing Chen, Wei Zeng, Kuanhan Feng, Yu Zheng, Ping Wang, Fucai Chen, Wen Zhang, Liuqing Di, Ruoning Wang.
Extracellular vesicles as biomarkers and drug delivery systems for tumor[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(7)
: 3460
-3486
.
DOI: 10.1016/j.apsb.2025.04.033
Year 2025 volume 15 Issue 7
PDF
5
2
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.04.033
- Receive Date:2024-12-02
- Online Date:2026-09-17